Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Urinary Tract Infection Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Diabetes and Kidney Stones
5.1.1.2. High Incidences of UTI in Female Population
5.1.1.3. Complicated UTI due to Rise in Excessive Use of Antibiotics and Drug-Resistance
5.1.2. Restraints
5.1.2.1. Adverse Effects of Urinary Tract Infection Treatment Drugs such as Aminoglycosides and Azoles
5.1.3. Opportunities
5.1.3.1. Rise in R&D for a Novel Class of Antibiotics, Vaccines, and Devices
5.1.3.2. Increase in Awareness among People and Healthcare Expenditure
5.1.4. Challenges
5.1.4.1. Social Stigma Concerning Urinary Tract Infections
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Urinary Tract Infection Market, by Clinical Indication
6.1. Introduction
6.2. Cystitis
6.3. Pyelonephritis
6.4. Urethritis

7. Urinary Tract Infection Market, by Treatment
7.1. Introduction
7.2. Diagnosis
7.3. Therapatics
7.4.1. Aminoglycosides
7.4.2. Azoles
7.4.3. Quinolones
7.4.4. ?-lactam

8. Urinary Tract Infection Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Self-Administered

9. Americas Urinary Tract Infection Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Urinary Tract Infection Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Urinary Tract Infection Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Almirall, S.A.
13.1.3. AstraZeneca PLC
13.1.4. Bayer AG
13.1.5. Boehringer Ingelheim International GmbH
13.1.6. Bristol-Myers Squibb Company
13.1.7. Cipla Inc.
13.1.8. Dr. Reddys Laboratories Ltd.
13.1.9. Eli Lilly and Company
13.1.10. F. Hoffmann-La Roche AG
13.1.11. GlaxoSmithKline PLC
13.1.12. Johnson & Johnson
13.1.13. Merck & Co. Inc.
13.1.14. Mindray Medical International Limited
13.1.15. Novartis AG
13.1.16. Novo Nordisk A/S
13.1.17. Pfizer Inc.
13.1.18. Shionogi & Co., Ltd.
13.1.19. Siemens Healthcare AG
13.1.20. Sun Pharmaceutical Industries Limited
13.1.21. Sysmex Corporation
13.1.22. Teva Pharmaceutical Industries Ltd.
13.1.23. Urit Medical Electronic Co., Ltd.
13.1.24. Viatris Inc.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. URINARY TRACT INFECTION MARKET RESEARCH PROCESS
FIGURE 2. URINARY TRACT INFECTION MARKET SIZE, 2022 VS 2030
FIGURE 3. URINARY TRACT INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. URINARY TRACT INFECTION MARKET DYNAMICS
FIGURE 7. URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2022 VS 2030 (%)
FIGURE 8. URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 10. URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 12. URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. URINARY TRACT INFECTION MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. URINARY TRACT INFECTION MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. URINARY TRACT INFECTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. URINARY TRACT INFECTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL URINARY TRACT INFECTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 6. URINARY TRACT INFECTION MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. URINARY TRACT INFECTION MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. URINARY TRACT INFECTION MARKET SIZE, BY URETHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 10. URINARY TRACT INFECTION MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 13. URINARY TRACT INFECTION MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. URINARY TRACT INFECTION MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. URINARY TRACT INFECTION MARKET SIZE, BY QUINOLONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. URINARY TRACT INFECTION MARKET SIZE, BY ?-LACTAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. URINARY TRACT INFECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. URINARY TRACT INFECTION MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 34. CANADA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. CANADA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 36. CANADA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 40. MEXICO URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES URINARY TRACT INFECTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. CHINA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 56. CHINA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. CHINA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 58. CHINA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. INDIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 60. INDIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. INDIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 62. INDIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 68. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 70. JAPAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 92. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 94. THAILAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA URINARY TRACT INFECTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 105. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 106. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 107. DENMARK URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 109. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 111. EGYPT URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 113. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 115. FINLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 117. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 121. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 122. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 123. GERMANY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. ITALY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 129. ITALY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 130. ITALY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 131. ITALY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 141. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 143. NORWAY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. POLAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 145. POLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. POLAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 147. POLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. QATAR URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 149. QATAR URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. QATAR URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 151. QATAR URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 165. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 178. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 179. TURKEY URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY CLINICAL INDICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY THERAPATICS, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM URINARY TRACT INFECTION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. URINARY TRACT INFECTION MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 189. URINARY TRACT INFECTION MARKET SHARE, BY KEY PLAYER, 2022
TABLE 190. URINARY TRACT INFECTION MARKET LICENSE & PRICING